A targeting approach for delivery of polymer microparticle-antibody conjugate against Vibrio parahaemolyticus-induced cytotoxicity to human intestinal epithelial cells

References

• Alam MJ, Miyoshi S, Shinoda S. Studies on pathogenic Vibrio parahaemolyticus during a warm weather season in the Seto inland sea, Japan. Environ Microbiol 2003; 5: 706–710
   PubMed Web of Science ®Google Scholar
• Aybay C, Imir T. Development of a rapid, single-step procedure using protein G affinity chromatography to deplete fetal calf serum of its IgG and to isolate murine IgG1 monoclonal antibodies from supernatants of hybridoma cells. J Immunol Methods 2000; 233: 77–81
   PubMed Web of Science ®Google Scholar
• Hara-Kudo Y, Sugiyama K, Nishibuchi M. Prevalence of pandemic thermostable direct hemolysin-producing Vibrio parahaemolyticus O3:K6 in seafood and the coastal environment in Japan. Appl Environ Microbiol 2003; 69: 3883–3891
   PubMed Web of Science ®Google Scholar
• Hilgers AR, Conradi RA, Burton PS. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm Res 1990; 7: 902–910
   PubMed Web of Science ®Google Scholar
• Honda T, Ni Y, Miwatani T. Purification and characterization of a hemolysin produced by a clinical isolate of Kanagawa phenomenon-negative Vibrio parahaemolyticus and related to the thermostable direct hemolysin. Infect Immun 1988; 56: 961–965
   PubMed Web of Science ®Google Scholar
• Honda T, Ni Y, Miwatani T. Purification of a TDH-related hemolysin produced by a Kanagawa phenomenon-negative clinical isolate of Vibrio parahaemolyticus 06:K46. FEMS Microbiol Lett 1989a; 48: 241–245
   PubMedGoogle Scholar
• Honda T, Ni Y, Yoh M, Miwatani T. Production of monoclonal antibodies against thermostable direct hemolysin of Vibrio parahaemolyticus and application of the antibodies for enzyme-linked immunosorbent assay. Med Microbiol Immunol 1989b; 178: 245–253
   PubMed Web of Science ®Google Scholar
• Honda T, Honda S, Ni YX, Miwatani T. Development and application of enzyme-linked immunosorbent assay using monoclonal antibody against a hemolysin (Vp-TRH) of Vibrio paraheamolyticus–evidence that Vp-TRH producing-Kanagawa phenomenon-negative V. parahaemolyticus is a human pathogen. Kansenshogaku Zasshi 1990; 64: 767–773
   PubMedGoogle Scholar
• Iida T, Suthienkul O, Park KS. Evidence for genetic linkage between the ure and trh genes in Vibrio parahaemolyticus. J Med Microbiol 1997; 46: 639–645
   PubMed Web of Science ®Google Scholar
• Iida T, Park KS, Suthienkul O. Close proximity of the tdh, trh and ure genes on the chromosome of Vibrio parahaemolyticus. Microbiology 1998; 144: 2517–2523
   PubMed Web of Science ®Google Scholar
• Kawamura N, Yamazaki T, Tamai H. Risk factors for the development of Escherichia coli O157:H7 associated with hemolytic uremic syndrome. Pediatr Int 1999; 41: 218–222
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough N, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 257–265
   Google Scholar
• Nagayama K, Oguchi T, Arita M, Honda T. Correlation between cell-associated mannose-sensitive hemagglutination by Vibrio parahaemolyticus and adherence to a human colonic cell line Caco-2. FEMS Microbiol Lett 1994; 120: 207–210
   PubMed Web of Science ®Google Scholar
• Nagayama K, Yamamoto K, Mitawani T, Honda T. Characterisation of a haemolysin related to Vp-TDH produced by a Kanagawa phenomenon-negative clinical isolate of Vibrio parahaemolyticus. J Med Microbiol 1995; 42: 83–90
   PubMedGoogle Scholar
• Nakao H, Kiyokawa N, Fujimoto J, Yamasaki S, Takeda T. Monoclonal antibody to Shiga toxin 2 which blocks receptor binding and neutralizes cytotoxicity. Infect Immun 1999; 67: 5717–5722
   PubMed Web of Science ®Google Scholar
• Nasu H, Iida T, Sugahara T. A filamentous phage associated with recent pandemic Vibrio parahaemolyticus O3:K6 strains. J Clin Microbiol 2000; 38: 2156–2161
   PubMed Web of Science ®Google Scholar
• Nishibuchi M, Fasano A, Russell RG, Kaper JB. Enterotoxigenicity of Vibrio parahaemolyticus with and without genes encoding thermostable direct hemolysin. Infect Immun 1992; 60: 3539–3545
   PubMed Web of Science ®Google Scholar
• Ohta K, Kudoh Y, Tsuno M. Development of a sensitive serological assay based on reversed passive hemagglutination for detection of enteropathogenic toxin (kanagawa hemolysin) of Vibrio parahaemolyticus, and re-evaluation of the toxin producibility of isolates from various sources. Nippon Saikingaku Zasshi 1979; 34: 837–846
   PubMedGoogle Scholar
• Osawa R, Arakawa E, Okitsu T, Yamai S, Watanabe H. Levels of thermostable direct hemolysin produced by Vibrio parahaemolyticus O3:K6 and other serovars grown anaerobically with the presence of a bile acid. Curr Microbiol 2002; 44: 302–305
   PubMed Web of Science ®Google Scholar
• Pallasch TJ. Antibiotic resistance. Dent Clin North Am 2003; 47: 623–639
   PubMedGoogle Scholar
• Rakita RM, Quan VC, Jacques-Palaz K. Specific antibody promotes opsonization and PMN-mediated killing of phagocytosis-resistant Enterococcus faecium. FEMS Immunol Med Microbiol 2000; 28: 291–299
   PubMed Web of Science ®Google Scholar
• Rivier D, Sobotka J. Protective effect of rabbit immune serum administered orally to rats infected by a human pathogenic strain of E. coli. Exp Cell Biol 1978; 46: 277–288
   PubMedGoogle Scholar
• Safdar N, Said A, Gangnon RE, Maki DG. Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: A meta-analysis. JAMA 2002; 288: 996–1001
   PubMed Web of Science ®Google Scholar
• Siiman O, Burshteyn A, Insausti ME. Covalently bound antibody on polystyrene latex beads: Formation, stability, and use in analyses of white blood cell populations. J Colloid Interface Sci 2001; 234: 44–58
   PubMed Web of Science ®Google Scholar
• Suthienkul O, Iida T, Park KS. Restriction fragment length polymorphism of the tdh and trh genes in clinical Vibrio parahaemolyticus strains. J Clin Microbiol 1996; 34: 1293–1295
   PubMed Web of Science ®Google Scholar
• Widders PR, Thomas LM, Long KA, Tokhi MA, Panaccio M, Apos E. The specificity of antibody in chickens immunised to reduce intestinal colonisation with Campylobacter jejuni. Vet Microbiol 1998; 64: 39–50
   PubMed Web of Science ®Google Scholar
• Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 2000; 342: 1930–1936
   PubMed Web of Science ®Google Scholar
• Xu M, Iida T, Yamamoto K, Takarada Y, Miwatani T, Honda T. Demonstration and characterization of simultaneous production of a thermostable direct hemolysin (TDH/I) and a TDH-related hemolysin (TRHx) by a clinically isolated Vibrio parahaemolyticus strain, TH3766. Infect Immun 1994; 62: 166–171
   PubMed Web of Science ®Google Scholar
• Yeung PS, Hayes MC, DePaola A, Kaysner CA, Kornstein L, Boor KJ. Comparative phenotypic, molecular, and virulence characterization of Vibrio parahaemolyticus O3:K6 isolates. Appl Environ Microbiol 2002; 68: 2901–2909
   PubMed Web of Science ®Google Scholar
• Yoh M, Honda T. The stimulating effect of fosfomycin, an antibiotic in common use in Japan, on the production/release of verotoxin-1 from enterohaemorrhagic Escherichia coli O157:H7 in vitro. Epidemiol Infect 1997; 119: 101–103
   PubMed Web of Science ®Google Scholar